Your cart is empty.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
Männedorf, Switzerland, December 06, 2011 –
The Infinite M1000 PRO is Tecan’s latest generation high-end multimode microplate reader, packed with applicationfocused functions and technical innovations to offer exceptional speed and sensitivity for academic, biotechnology and pharmaceutical research, including a module designed specifically for AlphaScreen and AlphaLISA technologies. Based on Tecan’s premium Quad4 Monochromators™, its patented technology allows fine tuneable and precise bandwidth adjustment in fluorescence, as well as offering Tecan’s highly acclaimed absorbance, fluorescence and luminescence scanning capabilities.
The new AlphaScreen module includes dedicated filters for both AlphaScreen and AlphaLISA assays, as well as an ingenious temperature correction function that can compensate for sample temperature variations across the microplate. This novel system helps to accelerate analysis of these highly temperature-sensitive assays by eliminating the need for time-consuming equilibration of plates, increasing productivity without compromising on quality of results.
The instrument’s class-leading format flexibility offers pre- and user-defined microplate formats from 6- to 1,536-wells, as well as compatibility with Tecan’s patent pending NanoQuant Plate™ for low volume nucleic acid measurements. It also incorporates a range of application-specific functions – such as Optimal Read (OR) and double orbital shaking – designed to accelerate and simplify experimental workflows and analysis, providing a comprehensive solution for your research needs.
To learn more about the new Infinite M1000 PRO, visit www.tecan.com/infinitem1000pro
AlphaScreen and AlphaLISA are registered trademarks of PerkinElmer, USA.
For more information please contact
Tecan Trading AG
Tanja Sager
Seestrasse 103
CH-8708 Männedorf
Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12
About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2010, Tecan generated sales of CHF 371 million (USD 356 million; EUR 269 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN: 1210019).